Stocks
Immunome (IMNM) Net profit US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net profit, bln rub | ? | -10.6 | -17.1 | -24.5 | -37.5 | -106.8 | -232.0 | ||
| Changes by years, y/y, % | +34% | +62% | +43% | +53% | +185% | +68.6% | |||
Immunome. Net profit US GAAP, bln rub
Immunome. Net profit US GAAP, changes, %
Immunome. Net profit US GAAP, sum by quarters, bln rub
Immunome (IMNM) Net profit US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net profit, bln rub | ? | -4.07 | -5.56 | -4.35 | -92.6 | -129.5 | -232.0 | |
| Changes by years, y/y, % | -65% | -38% | -49% | +1 002% | +3 082% | |||
| Changes by quarters, q/q, % | -52% | +37% | -22% | +2 032% | +40% | |||
